Fierce Pharma

APRIL 18, 2023

Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48

Biopharma 246

Biopharma Patients 246

Fierce Pharma

JANUARY 8, 2024

Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P. In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity. Morgan Healthcare Conference. |

Prospecting 302

Prospecting Biopharma Pharma Healthcare 302

Fierce Pharma

MARCH 21, 2023

Biopharma industry lobbies for tax breaks related to US-based manufacturing kdunleavy Tue, 03/21/2023 - 11:14

Biopharma 264

Biopharma Manufacturing 264

Fierce Pharma

JANUARY 16, 2024

2023 was riddled with labor strikes across industries as workers lobbied for higher pay amid economic headwinds that shook up the global economy. | A USA Today review of millions of Glassdoor ratings found that employees in the biopharma industry are the most satisfied with their pay compared with other fields.

Biopharma 264

Biopharma 264

Fierce Pharma

MAY 25, 2023

The Top Line': The 20 most influential people in biopharma, plus this week's headlines tcarey Thu, 05/25/2023 - 14:21

Biopharma 244

Biopharma 244

Fierce Pharma

APRIL 19, 2023

Alnylam, Intra-Cellular among analyst's top picks for M&A as biopharma dealmaking heats up aliu Wed, 04/19/2023 - 14:39

Biopharma 245

Biopharma 245

Fierce Pharma

MAY 9, 2023

Let's make a deal: Conditions are right for biopharma M&A to break out, analysts say kdunleavy Tue, 05/09/2023 - 10:18

Biopharma 246

Biopharma 246

Fierce Pharma

DECEMBER 22, 2023

Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

Biopharma 350

Biopharma 350

Fierce Pharma

JANUARY 3, 2024

Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk and Eli Lilly—overwhelming the market wi | Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk (..)

Sales 321

Sales Biopharma Leads Marketing 321

Fierce Pharma

FEBRUARY 21, 2024

In a year that started with more than two-thirds of biopharma companies posting | While Novo Nordisk and Eli Lilly continued to be the biopharma industry growth leaders in the fourth quarter of 2023, many other drugmakers also delivered big gains, including Daiichi Sankyo, Amgen, Teva, GSK and Novartis.

Leads 312

Leads Biopharma Sales 312

Fierce Pharma

MAY 18, 2023

The Top Line': 2023's biopharma layoffs, plus this week's headlines tcarey Thu, 05/18/2023 - 16:13

Biopharma 147

Biopharma 147

Fierce Pharma

JANUARY 23, 2023

Call for nominations: The most influential people in biopharma in 2023 esagonowsky Mon, 01/23/2023 - 14:32

Biopharma 130

Biopharma 130

Fierce Pharma

MAY 9, 2023

We want your stories: Biopharma's collective memory of COVID—in photographs aliu Tue, 05/09/2023 - 14:56

Biopharma 162

Biopharma 162

Fierce Pharma

NOVEMBER 22, 2022

2023 preview: Despite Biden's drug pricing win, the biopharma industry is not 'anywhere near done with this conversation'. esagonowsky. Tue, 11/22/2022 - 14:22.

Biopharma 130

Biopharma 130

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Are you coming to the CPHI Barcelona 2023?

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

Pharma Pathway

FEBRUARY 28, 2023

Hetero Biopharma-Walk-In Interview for M.Sc/ B.Sc/ Diploma in Production On 4th Mar’ 2023 Job Description Greetings from Hetero Biopharma !!! Walk-In Interview for M.Sc/ B.Sc/ Diploma in Production @ Hetero Biopharma Department: Production Designation: Executive to Sr. 7-2-A2, Sanath Nagar, Opp.

Biopharma 81

Biopharma Pharma 81

European Pharmaceutical Review

FEBRUARY 21, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL (..)

Pharmaceutical 111

Pharmaceutical Biopharma Consulting Pharma 111

Pharma Pathway

FEBRUARY 23, 2023

Position: 26 Date: 26th Feb’ 2023 Time: 10:00 AM to 03:00 PM Venue: Celebrity Biopharma Limited, Vill -Panga Hilltop, Estate Via Jharmajri Distt. Celebrity Biopharma Limited (Aishwarya Group)-Walk-In Interviews for QA/ QC/ Production On 26th Feb’ 2023

Biopharma 80

Biopharma Pharma 80

PharmExec

OCTOBER 13, 2023

Exploring the pharma and biotech financing, M&A, and stock market pictures through the first half of 2023—and implications for the future, as market challenges continue to weigh heavily in senior management decision-making.

Marketing 104

Marketing Biopharma Pharma Management 104

MedCity News

DECEMBER 15, 2022

2023 is shaping up to be a crucial year for everyone involved – and affected – by the pharmaceutical industry. It’s likely to be a year of experimentation for payers – and defensiveness for drug makers.

Insurance 118

Insurance Pharma Pharmaceutical Biopharma 118

European Pharmaceutical Review

OCTOBER 2, 2023

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. CPHI creates connections and inspires partnerships across the global pharma community. CPHI creates connections and inspires partnerships across the global pharma community.

Manufacturing 105

Manufacturing Pharma Engineering Networking 105

European Pharmaceutical Review

DECEMBER 20, 2023

In Q1 2023, the European Commission (EC) announced proposed changes to EU pharmaceutical legislation. 1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. analysis (Source: L.E.K) What are the latest amendments?

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

European Pharmaceutical Review

AUGUST 24, 2023

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. Venture funding in 2022 came in at about $13.7 billion, down from the high of 2021.

Biopharma 98

Biopharma Pharmaceutical Pharma Medical 98

MedCity News

MARCH 24, 2024

based pharma companies. The survey was conducted in late 2023 and results were reported this month. Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based

Pharma 104

Pharma Biopharma 104

European Pharmaceutical Review

OCTOBER 27, 2022

Ahead of the world’s largest pharma event, CPHI Frankfurt – hosted at the Frankfurt Messe (1-3 November, 2022) – part i of the CPHI Annual Report looks ahead at the opportunities for biologics outsourcing and contract manufacturing organisastions (CMOs) in 2023. percent in 2022.

Biopharma 98

Biopharma Manufacturing Pharmacology Training 98

pharmaphorum

DECEMBER 23, 2022

And in 2023, these investments will hopefully pay off. With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Marketing data will surpass health data as a leading signal for pharma advertisers.

Marketing 105

Marketing Sales Medical Patients 105

European Pharmaceutical Review

JANUARY 12, 2023

Out of 19 companies honoured with the 2022 Terra Carta Seal, the three pharma companies awarded were: GlaxoSmithKline PLC. Being awarded the 2022 Terra Carta Seal is confirmation of GSK demonstrating its commitment to climate responsibility for its supply chain in force from 2023. Samsung Biologics.

Pharma 105

Pharma Biopharma Manufacturing Government 105

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

MedCity News

DECEMBER 29, 2022

Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.

Pharma 98

Pharma Medical Biopharma 98

Pharma Pathway

FEBRUARY 14, 2023

Manvi Biopharma Pvt. Ltd- Walk-In Interviews for Production/ Quality Control On 15th Feb’ 2023 Job Description Walk-In Interviews for Production/ Quality Control On 15th Feb’ 2023 @ Manvi Biopharma Pvt. Manvi Biopharma Pvt. Ltd Department: Production/ Quality Control Posts: Chemist/ Sr.

Biopharma 52

Biopharma Pharma 52

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128

Pharma Pathway

FEBRUARY 3, 2023

Hetero Biopharma-Walk-In Interview for M.Sc/ B.Tech Biochemistry/ Biotechnology in Production On 4th Feb’ 2023 Job Description Greetings from Hetero Biopharma !!! Walk-In Interview for M.Sc/ B.Tech Biochemistry/ Biotechnology in Production @ Hetero Biopharma Department: Production Designation: Executive to Sr.

Biopharma 52

Biopharma Pharma 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B. Braun Medical, Inc.

Education 122

Education Marketing Media Pharmaceutical 122

Zymewire

JANUARY 24, 2024

Unlocking the financial pulse of the biotech and pharma industry. A must-read for sales professionals navigating the terrain of biotech and pharma funding

Biopharma 52

Biopharma Pharma Sales 52

MedCity News

APRIL 13, 2023

Rejection of Eli Lilly’s mirikizumab means that two of the four drugs the pharma giant identified as revenue growth drivers for 2023 have failed to pass the regulatory bar. One of those drugs has been approved while the fourth drug still awaits an FDA decision.

FDA 119

FDA Manufacturing Pharma Biopharma 119

European Pharmaceutical Review

NOVEMBER 30, 2023

Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. As a result, 2023 saw an upsurge in merger and acquisition (M&A) and deal activity. According to BioWorld, M&A values in 2023 jumped 80% over 2022, and deal values reached BioWorld’s highest level ever recorded.

Pharma 59

Pharma Biopharma Prospecting Competition 59